About Ibalizumab API

High-Purity Ibalizumab API for HIV-1 Treatment

Ibalizumab API is a pharmaceutical-grade humanized monoclonal antibody developed for the treatment of multidrug-resistant HIV-1 infection in combination with other antiretroviral therapies. It binds to the CD4 receptor on host immune cells, preventing HIV from entering cells without suppressing normal immune function.

Ibalizumab is indicated for adults with multidrug-resistant HIV-1 who have limited treatment options. Its unique mechanism of action makes it an important component of modern HIV management.

Manufactured under WHO-GMP-certified facilities, our Ibalizumab API provides exceptional purity, biological activity, stability, and batch-to-batch consistency. Complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and Technical Data Sheet (TDS), is supplied with every batch.

Key Features

High-purity biopharmaceutical API
Humanized monoclonal antibody
Anti-HIV-1 activity
High biological stability
WHO-GMP certified manufacturing
Low impurity profile
Complete CoA & MSDS
Batch-to-batch consistency
Sterile manufacturing process
Worldwide bulk supply

Applications

HIV-1 treatment
Multidrug-resistant HIV therapy
Injectable biologic formulations
Antiretroviral medicines
Biopharmaceutical manufacturing
Clinical research
Biotechnology research
Pharmaceutical development

Why Choose Swapnroop Pharma

WHO-GMP Certified Manufacturing
Advanced Biopharmaceutical Facility
High-Purity Monoclonal Antibody APIs
Complete Regulatory Documentation
Competitive Bulk Pricing
Reliable Worldwide Export
Technical & Regulatory Support
Consistent Product Quality

Packaging & Supply

Available Packaging

100 mg
500 mg
1 g
Custom Bulk Packaging Available

Documentation Provided

Certificate of Analysis (CoA)
Material Safety Data Sheet (MSDS)
Technical Data Sheet (TDS)
Product Specification Sheet
Batch Manufacturing Record

Frequently Asked Questions (FAQs)

1. What is Ibalizumab API used for?

Ibalizumab API is used in combination with other antiretroviral medicines for the treatment of multidrug-resistant HIV-1 infection.

2. How does Ibalizumab work?

It binds to the CD4 receptor on immune cells, preventing HIV-1 from entering host cells while preserving normal immune function.

3. Is regulatory documentation available?

Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation.

4. Is bulk commercial supply available?

Yes. We supply Ibalizumab API in commercial quantities with worldwide export support.

Get Bulk Quote via WhatsApp